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Background: Guidelines are viewed as a mechanism for
disseminating a rapidly increasing body of knowledge.
We determined the compliance of Dutch general practi-
tioners with the recommendations for blood test order-
ing as defined in the guidelines of the Dutch College of
General Practitioners.
Methods: We performed an audit of guideline compli-
ance over a 12-month period (March 1996 through Feb-
ruary 1997). In an observational study, a guideline-
based decision support system for blood test ordering,
BloodLink, was integrated with the electronic patient
records of 31 general practitioners practicing in 23 prac-
tices (16 solo). BloodLink followed the guidelines of the
Dutch College of General Practitioners. We determined
compliance by comparing the recommendations for test
ordering with the test(s) actually ordered. Compliance
was expressed as the percentage of order forms that
followed the recommendations for test ordering.
Results: Of 12 668 orders generated, 9091 (71%) used the
decision-support software rather than the paper order
forms. Twelve indications accounted for >80% of the
7346 order forms that selected a testing indication in
BloodLink. The most frequently used indication for test
ordering was “vague complaints” (2209 order forms;
30.1%). Of the 7346 order forms, 39% were compliant.
The most frequent type of noncompliance was the
addition of tests. Six of the 12 tests most frequently
added to the order forms were supported by revisions of
guidelines that occurred within 3 years after the inter-
vention period.
Conclusions: In general practice, noncompliance with
guidelines is predominantly caused by adding tests. We
conclude that noncompliance with a guideline seems to
be partly caused by practitioners applying new medical
insight before it is incorporated in a revision of that
guideline.
© 2002 American Association for Clinical Chemistry
Dutch investigators report that a lack of general practitio-
ners’ knowledge concerning the indications for blood
tests leads to inappropriate use of diagnostic tests (1 ).
Investigators argue that improving the quality of blood
test ordering deserves attention (2, 3).
To deal with the rapidly expanding body of medical
knowledge, guidelines are increasingly viewed as a mech-
anism for distributing knowledge to practitioners (4, 5).
In The Netherlands, the Dutch College of General Practi-
tioners issues guidelines for the general practitioner. The
procedure for creating a guideline consists of four stages
(6 ). The first stage involves the selection of topics for new
guidelines by an independent advisory board. In the
second stage, a small taskforce, consisting of four to eight
general practitioners with special interest in and expertise
on the topic of that guideline, prepares a draft. This draft
is based on a review of the available literature, current
medical practice, and consensus in the taskforce with
respect to appropriate medical practice in primary care. In
the third stage, a random sample of general practitioners
and specialists reviews this draft. The final stage involves
authorization of the guideline by a board consisting of
leading general practitioners. After authorization, the
guideline is published in the journal of the Dutch College
of General Practitioners. After publication, the guidelines
are revised at regular intervals.
Even when authoritative guidelines are available,
changing the behavior of physicians is difficult (7–10).
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Investigators acknowledge that the dissemination and
implementation of guidelines constitute an important
research area that must be addressed (11–13). Dissemina-
tion of guidelines alone is not enough; it needs to be
combined with an appropriate implementation strategy
(2, 14), including an educational strategy (15 ). Some au-
thors argue that the use of electronic patient records will
provide new opportunities for decision support
(11, 16, 17); integration of decision support facilities with
the electronic patient record may provide a natural way to
integrate that support in day-to-day practice (18–20).
Recently, Shiffman et al. (21 ) analyzed the functionality
and effectiveness of computer-based guideline implemen-
tation and reported that guideline adherence improved in
14 of 18 systems in which it was measured.
In The Netherlands, the majority of general practitio-
ners have replaced their traditional paper-based medical
records with electronic patient records to record medical
data during patient encounters (22 ). We have built a
test-ordering module, BloodLink, which is integrated
with the electronic patient record to support the general
practitioner in requesting blood tests. Our objective was
to improve adherence to the guidelines by implementing
a test-ordering module that provides the general practi-
tioner with recommendations for test ordering based on
these guidelines. In a randomized trial, BloodLink led to a
significant reduction of the number of tests ordered by the
general practitioners (23 ).
The impact of BloodLink on the volume of tests or-
dered is not necessarily an indication of the degree of
compliance to the guidelines. In this study, we deter-
mined the compliance of Dutch general practitioners with
the recommendations for blood test ordering as defined in
the guidelines of the Dutch College of General Practitio-
ners. We will first, however, briefly describe BloodLink.
BloodLink
By January 1996, the Dutch College of General Practitio-
ners had published 54 guidelines covering most clinical
situations in primary care. We analyzed the version of
each guideline available in January 1996 (24 ). If the
guideline contained a reference to a blood test, we deter-
mined (a) the clinical situation in which the test should be
performed (the indication) and (b) the tests that should be
performed in that situation (the advised tests).
Of the 54 guidelines, 23 guidelines addressed blood
tests and allowed us to identify the indications for those
tests (24 ). We distinguished five categories of indications
for the following clinical situations: (a) the use of blood
tests to support or refute a provisional diagnosis; (b) the
use of blood tests to investigate the underlying pathology
that could be causing the already diagnosed disease; (c)
monitoring the course of a disease; (d) the use of blood
tests to select appropriate treatment; and (e) monitoring
side effects of drugs.
BloodLink, which is based on these five categories of
indications and covers 66 different indications, contains a
total of 37 different tests (24 ).
The general practitioner, using the electronic patient
record, can activate BloodLink to order blood tests. Blood-
Link first provides an overview of the available guide-
lines. The general practitioner selects the appropriate
guideline. BloodLink queries the general practitioner
about the reasons for requesting the tests until an indica-
tion is identified, e.g., the guideline “blood tests and liver
disease” mentions 10 different indications, and the mod-
ule asks for the disease involved (e.g., hepatitis B) and the
indication (e.g., monitoring the course of hepatitis B).
Optional help texts are available that explain the choices
and provide the relevant sections of the guidelines. After
the indication has been identified, the system proposes
the relevant tests. BloodLink does not cover all possible
indications for blood tests in primary care. To deal with
these situations, the general practitioner can select the
heading “other indication” and type the initial letter of the
desired test. BloodLink prints a hardcopy order form for
the laboratory. In addition, BloodLink logs the physician’s
use of the system and stores the order in the electronic
patient record.
Guideline implementation occurs in the context of
conflicting pressures for clinical autonomy and profes-
sional standardization and quality improvement (25–27).
Although the guidelines are explicit but crude summaries
of both “state of the art” evidence-based medicine and
implicit skills, they should be used not to dictate practice
but to inform clinical judgment. Moreover, patients have
multiple problems and often present with nonspecific
symptoms. The indication-oriented test protocols of
BloodLink, therefore, are only a recommendation to the
physician. The general practitioner makes the decision of
protocol adherence. At any time, the practitioner may
adapt the test ordering to the patient-specific clinical
situation by adding or removing tests from the list pro-
posed by BloodLink.
Materials and Methods
The study was an audit of guideline compliance over a
12-month period and was part of a larger study reported
previously (23 ). In August and September 1995, the
general practitioners in the region of Delft (a total of 94
practitioners in 64 practices) were asked to participate in
a trial in which we studied test-ordering behavior (23 ). Of
these 64 practices, 44 agreed to participate. Of these 44
practices, 24 practices involving 32 practitioners were
assigned to use the BloodLink decision support system
based on the guidelines of the Dutch College of General
Practitioners. During a 3-month period, the general prac-
titioners were allowed to use BloodLink in their practices.
After this period, the general practitioners were asked
whether they wished to start the study. One practitioner
did not want to proceed, stating that he did not like the
software. During the study period, the participating gen-
eral practitioners did not receive any feedback. The me-
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dian enrolled population per practice was 3205, the me-
dian average age of population was 37.6 years, and the
median percentage of females was 49.9%.
The study period was March 1996 through February
1997. We logged the use of the BloodLink software in the
general practitioners’ offices by recording the use of the
software in the patients’ medical records. For test order-
ing, the physicians were not forced to use the BloodLink
software; paper order forms remained available during
the entire intervention period.
For all indications, we counted the frequency of use
and the number of tests added to or removed from the
proposed test panel per practice. Protocol compliance was
measured by comparing the BloodLink test recommenda-
tions with the tests actually ordered per indication. If the
physician did not change the recommendations of Blood-
Link, we labeled the order form as compliant. If the
physician did modify the recommendations, we labeled
the order form as noncompliant. The noncompliant order
forms were subsequently classified into one of three
categories. If the physician only added tests, we classified
the order form as noncompliant by addition of tests. If the
physician only removed tests, we classified the order form
as noncompliant by removal of tests. If the physician both
removed and added tests, we classified the order form as
noncompliant by both addition and removal of tests. The
main outcome measure was the percentage of order forms
compliant with the recommendations for test ordering of
the guidelines of the Dutch College of General Practitio-
ners.
In October 1999, we analyzed which guidelines involv-
ing test ordering had been updated by the Dutch College
of General Practitioners after the end of the intervention
period (i.e., after February 28, 1997). To assess whether
noncompliance was related to these changes in the guide-
lines, we determined whether the updated guidelines
included indications that recommended the three most
frequently added tests.
Results
For test ordering, the general practitioner had the choice
to use either the BloodLink software or a paper form. Of
the 12 668 order forms generated, 9091 (71%) used the
decision-support software. For 7346 of these 9091 order
forms, general practitioners selected an indication listed
in BloodLink, with a total of 66 different indications. As
shown in Table 1, 12 indications accounted for 80% of
the 7346 order forms; the most frequently used indication
was “vague complaints”, which accounted for 2209 of the
7346 order forms (30.1%). When the general practitioner
could not find the indication, BloodLink allowed the
general practitioner to enter the indication and select tests.
Of the 9091 forms, the general practitioner entered an
indication and selected tests in 1745 order forms; these
1745 order forms were excluded from further analysis.
After selecting the indication, the general practitioner
could change the recommendations of BloodLink. Of the
7346 order forms, 2874 (39.1%) were compliant with the
recommendations of BloodLink. The number of compliant
order forms per practice ranged from 10.2% to 60.9%. The
remaining 4472 order forms were noncompliant. Of the
7346 order forms, 262 (3.6%; range, 0–11.3%) were non-
compliant by removal of tests, 3337 (45.4%; range, 18.1–
81.0%) were noncompliant by addition of tests, and 873
(11.9%; range, 2.5–33.6%) were noncompliant by both
removal and addition of tests. When removing tests, the
general practitioner removed, on average, 1.4 tests. When
adding tests, the general practitioner added on average
2.9 tests. Table 2 shows, per indication, the percentages of
compliant order forms, noncompliant order forms by
removal of tests, noncompliant order forms by addition of
tests, and noncompliant order forms by both removal and
addition of tests.
To assess whether noncompliance was related to pend-
ing revision of guidelines, we analyzed which guidelines
were revised after the intervention period. We found that
a total of 13 of 54 guidelines were revised after the
intervention period. Four of these revised guidelines
showed changed recommendations for test ordering: hy-
percholesterolemia, diabetes mellitus, sore throat, and
hypertension. In the revised guideline, the indications to
perform tests changed and recommendations for test
ordering were updated. In addition, new indications were
introduced. All revisions in the recommendations for test
Table 1. Most frequently used indications.
Indication Frequency, n % Cumulative %
Vague complaints 2209 30.1 30.1
Hypertension, assessing risk factors 666 9.1 39.2
Hypercholesterolemia, screening 629 8.6 47.7
Anemia, establishing diagnosis 346 4.7 52.5
Allergic rhinitis, establishing diagnosis 320 4.4 56.9
Hyperthyroidism, establishing diagnosis 313 4.3 61.2
Hypercholesterolemia, monitoring course of disease 275 3.7 64.9
Rheumatoid arthritis, establishing diagnosis 268 3.6 68.5
Infectious mononucleosis, establishing diagnosis 260 3.5 72.0
Prostate cancer, establishing diagnosis 232 3.2 75.2
Iron depletion anemia, establishing diagnosis 210 2.9 78.1
Diabetes mellitus, monitoring course of disease 155 2.1 80.2
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ordering involved adding more tests when compared
with the recommendations in the previous guidelines.
Compared with the previous guideline, the revised guide-
line for hypertension added potassium to the diagnostic
workup of new patients; the revised guideline for hyper-
cholesterolemia added, for certain patients (e.g., patients
who smoke or suffer from hypertension), the investiga-
tion of HDL-cholesterol and glucose to screen for addi-
tional risk factors; the revised guideline for sore throat
added a white blood cell count when leukemia or agran-
ulocytosis was suspected; and the revised guideline for
diabetes mellitus added hemoglobin A1c for monitoring
treatment and HDL-cholesterol and triglycerides for all
patients.
In Table 3, we compare the three most frequently
added tests in the noncompliant order forms with the
recommendations of the updated guidelines for hyper-
cholesterolemia, diabetes mellitus, sore throat, and hyper-
tension. In total, the general practitioners generated 2295
order forms by selecting an indication from these four
guidelines. The general practitioners used indications
from the guideline for hypercholesterolemia a total of
1037 times. Of these 1037 order forms, 398 (38.4%) were
compliant with the guidelines that were available during
the intervention period, whereas 639 (61.6%) were non-
compliant. Of the 639 noncompliant order forms, 4 (0.6%)
were noncompliant by removal of tests, 608 (95.2%) were
noncompliant by addition of tests, and 27 (4.2%) were
noncompliant by both removal and addition of tests.
When adding tests, the general practitioners added, on
average, 3.0 tests. The most frequently added tests were
for triglycerides, HDL-cholesterol, and glucose; of the 639
noncompliant order forms, 509 (79.7%) order forms in-
volved adding triglycerides, 506 (79.2%) involved adding
HDL-cholesterol, and 186 (29.1%) involved adding glu-
cose.
The general practitioners used indications from the
guideline for hypertension a total of 666 times. Of these
666 order forms, 343 (51.5%) were compliant and 323
(48.5%) were noncompliant. Of the 323 noncompliant
Table 2. Percentage of order forms per indication that were compliant, noncompliant by removal of tests, noncompliant by
addition of tests, and noncompliant by both removal and addition of tests.
Indication Compliant, %
Noncompliant by
removal of tests, %
Noncompliant by
addition of tests, %
Noncompliant by
both removal and
addition of tests, %
Vague complaints 26.6 6.3 42.1 25.0
Hypertension, assessing risk factors 51.5 3.9 38.4 6.2
Hypercholesterolemia, screening 41.5 0.0 58.2 0.3
Anemia, establishing diagnosis 27.8 2.6 64.5 5.1
Allergic rhinitis, establishing diagnosis 65.0 0.0 31.6 3.4
Hyperthryoidism, establishing diagnosis 45.4 0.0 53.7 0.9
Hypercholesterolemia, monitoring course of disease 41.1 0.0 58.6 0.3
Rheumatoid arthritis, establishing diagnosis 17.9 0.0 77.2 4.9
Infectious mononucleosis, establishing diagnosis 30.0 1.5 61.2 7.3
Prostate cancer, establishing diagnosis 78.9 0.0 21.1 0.0
Iron depletion anemia, establishing diagnosis 62.9 10.5 20.5 6.1
Diabetes mellitus, monitoring course of disease 16.1 2.6 70.3 11.0
Table 3. Most frequently added tests in the noncompliant order forms compared with recommendations of the
updated guideline.
Guideline
Noncompliant
forms, n
Test added
(% of noncompliant forms)
Recommended in
updated guideline
Hypercholesterolemia 639 Triglycerides (79.7) No
HDL-cholesterol (79.2) Yes
Glucose (29.1) Yes
Hypertension 323 Potassium (33.4) Yes
Hemoglobin (29.1) No
Triglycerides (26.9) No
Diabetes mellitus 226 Hemoglobin A1c (71.2) Yes
Triglycerides (19.9) Yes
HDL-cholesterol (19.0) Yes
Sore throat 182 ESRa (70.9) No
Hemoglobin (48.4) No
Glucose (24.7) No
a ESR, erythrocyte sedimentation rate.
58 van Wijk et al.: Compliance with Guideline-based Decision Support
order forms, 26 (8.1%) were noncompliant by removal of
tests, 256 (79.3%) were noncompliant by addition of tests,
and 41 (12.7%) were noncompliant by both removal and
addition of tests. When adding tests, the general practi-
tioners added, on average, 2.8 tests. The most frequently
added tests were for potassium, hemoglobin, and triglyc-
erides; of the 323 noncompliant order forms, 108 (33.4%)
order forms involved adding potassium, 94 (29.1%) in-
volved adding hemoglobin, and 87 (26.9%) involved
adding triglycerides.
The general practitioners used indications from the
guideline for diabetes mellitus a total of 332 times. Of
these 332 order forms, 106 (31.9%) were compliant and
226 (68.1%) were noncompliant. Of the 226 noncompliant
order forms, 4 (1.8%) were noncompliant by removal of
tests, 195 (86.3%) were noncompliant by addition of tests,
and 27 (12.0%) were noncompliant by both the removal
and addition of tests. When adding tests, the general
practitioners added, on average, 2.5 tests. The most fre-
quently added tests were for hemoglobin A1c, triglycer-
ides, and HDL-cholesterol; of the 226 noncompliant order
forms, 161 (71.2%) order forms involved adding hemoglo-
bin A1c, 45 (19.9%) involved adding triglycerides, and 43
(19.0%) involved adding HDL-cholesterol.
The general practitioners used indications from the
guideline for sore throat a total of 260 times. Of these 260
order forms, 78 (30.0%) were compliant and 182 (70.0%)
order forms were noncompliant. Of the 182 noncompliant
order forms, 4 (2.2%) were noncompliant by removal of
tests, 159 (87.4%) were noncompliant by addition of tests,
and 19 (10.4%) were noncompliant by both removal and
addition of tests. When adding tests, the general practi-
tioner added, on average, 2.8 tests. The most frequently
added tests were for erythrocyte sedimentation rate, he-
moglobin, and glucose; of the 182 noncompliant order
forms, 129 (70.9%) order forms involved adding erythro-
cyte sedimentation rate, 88 (48.4%) involved adding he-
moglobin, and 45 (24.7%) involved adding glucose.
Discussion
In The Netherlands, the ordering of blood tests has been
the subject of numerous studies that attempted to reduce
the number of blood tests ordered by general practitioners
(1, 28–34). In a previous study, we reported that intro-
ducing indication-oriented test panels based on the guide-
lines of the Dutch College of General Practitioners re-
duced the number of tests ordered (23 ). The observed
reduction of the number of tests requested by the physi-
cian, however, does not necessarily mean that the physi-
cians adhered to the protocols. In this study, therefore, we
focused on protocol adherence.
Although BloodLink supports 66 indications, 12 indi-
cations accounted for 80% of the general practitioners’
use of the system. The most frequently used indication
was “vague complaints”, reflecting the morbidity in pri-
mary care. Primary care is characterized by its role in
diagnosing undifferentiated problems, often presenting
minor illness, or early stages of diseases. This pattern of
morbidity differs significantly from the morbidity in
secondary care. The fact that vague complaints was the
most common indication for test ordering is not surpris-
ing and is consistent with other studies in Dutch primary
care (34, 35).
Our study shows that removing tests from the recom-
mendations of the guidelines is rare compared with
adding tests. General practitioners seem to use the guide-
line-based test recommendations as a minimum for test
ordering in daily practice. Although the introduction of
BloodLink produced a clear reduction of the number of
tests ordered (23 ), this study shows that complete com-
pliance to the guidelines would have produced a still
larger reduction.
In our study, the addition of tests was the main cause
of noncompliance. Noncompliance, however, does not
necessarily indicate poor medical practice. A possible
reason for adding test is the fact that general practitioners
may have multiple indications for tests ordering. A pa-
tient presenting with an acute problem may also have a
chronic disease (e.g., diabetes mellitus) that requires pe-
riodic monitoring. The blood tests required for the acute
problem may be combined with the tests required for the
monitoring of the chronic disease in a single test order.
Our study shows another reason for adding tests:
anticipating pending changes in the guidelines. The
Dutch College of General Practitioners revises the guide-
lines periodically. Many of the modifications that caused
the order form to be noncompliant were supported by
subsequent revision of guidelines. For example, HDL-
cholesterol, which was added in 79.2% of the noncompli-
ant order forms, is included in the recommendations of
the revised guideline for hypercholesterolemia. Likewise,
hemoglobin A1c, which was added in 71.2% of the non-
compliant order forms, is included in the recommenda-
tions of the revised guideline for diabetes mellitus. Ap-
parently, general practitioners are aware of the new
medical evidence and anticipate pending changes in the
guidelines. Evidence-based medicine requires that guide-
lines be revised in the light of the available randomized
clinical trials. New trials first appear in medical journals
and are read by physicians. The evidence may subse-
quently lead to revision of guidelines. Adoption of recent
insight into daily practice, however, can precede dissem-
ination of revised guidelines. When physicians’ adherence
to guidelines is being audited, the dynamic nature of
guideline development must be taken into account. Ignor-
ing this dynamic nature of guidelines could lead to
penalties for physicians who apply the most recent
knowledge.
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